Combination therapy of botensilimab (BOT) plus balstilimab (BAL) was approved Monday as an updated national treatment protocol for patients with certain ovarian cancers and soft tissue sarcomas (STS) ...
Amazon's fantasy MMO is slated to go away for good in January 2027, unless someone—say, Facepunch COO Alistair ...